Back to Authors

Costello, Brian A.

https://orcid.org/0000-0003-1753-5928

Mayo Clinic

Mayo Clinic

Citations 155

A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).
Qin, Rui , Sicotte, Hugues , Carlson, Rachel E. , Tan, Winston , Jiménez, Rafael E. , Wang, Liewei , Eckel‐Passow, Jeanette E. , Costello, Brian A. , Pitot, Henry C., Dronca, Roxana , Wu, Kevin J. , Moynihan, Timothy J. , Atwell, Thomas D. , McMenomy, Brendan P., Kohli, Manish , Wang, Liguo , Quevedo, Fernando , Ho, Thai H. , Bryce, Alan H. , Dehm, Scott M.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2015.33.15_suppl.5056 Get It

Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).
Zhang, Ben Yiming, Riska, Shaun M., Lee, Adam M , Quevedo, Fernando , Costello, Brian A. , Pitot, Henry C., Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Silva, Fernando Eduardo Calais Da, Kochuparambil, Samith T. , Mahoney, Douglas W. , McDonnell, Shannon K. , Lee, Adam M. , Ribeiro, Ricardo , Medeiros, Rui , Cerhan, James R. , Kohli, Manish

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16117-e16117

10.1200/jco.2015.33.15_suppl.e16117 Get It

Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.
Zhang, Ben Yiming, Riska, Shaun M., Ribeiro, Ricardo , Medeiros, Rui , Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Calais-Da-Silva, Fernando, Costello, Brian A. , Dronca, Roxana , Pitot, Henry C., Moynihan, Timothy J. , Quevedo, Fernando , Mahoney, Douglas W. , Cerhan, James R. , Kohli, Manish

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2015.33.15_suppl.e16114 Get It

Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
Costello, Brian A. , Tan, Winston , Leibovich, Bradley C. , Castle, Erik P., Parker, Alexander S. , Dronca, Roxana , Qin, Rui , Ho, Thai H. , Kohli, Manish

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS4606-TPS4606

10.1200/jco.2014.32.15_suppl.tps4606 Get It

Chemotherapy for lung cancer in patients on renal replacement therapy: The Mayo Clinic experience.
Leventakos, Konstantinos , Sathick, Insara Jaffer , Finnes, Heidi D. , Costello, Brian A. , Molina, Julian R. , Mansfield, Aaron S. , Leung, Nelson

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e20569-e20569

10.1200/jco.2016.34.15_suppl.e20569 Get It

Genetic variation in sex hormone receptor genes and association with enzalutamide response in metastatic castration-resistant prostate cancer (mCRPC).
Zhang, Ben Yiming, Costello, Brian A. , Binder, Moritz , Quevedo, Fernando , Kohli, Manish

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16606-e16606

10.1200/jco.2016.34.15_suppl.e16606 Get It

Prognostic impact of genetic variation in steroidogenic enzymes in advanced stage prostate cancer.
Zhang, Ben Yiming, Costello, Brian A. , Kohli, Manish , Kohli, Manish , Binder, Moritz , Quevedo, Fernando

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16605-e16605

10.1200/jco.2016.34.15_suppl.e16605 Get It

Association of CYP17A1 single nucleotide polymorphism (SNP) with response to abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).
Zhang, Ben Yiming, Costello, Brian A. , Binder, Moritz , Quevedo, Fernando , Kohli, Manish

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16603-e16603

10.1200/jco.2016.34.15_suppl.e16603 Get It

Prospective front-line management patterns in the Real World Metastatic Renal Cell Cancer (MaRCC) Registry.
Wolf, Steven , Costello, Brian A. , Vaishampayan, Ulka N. , Kyriakopoulos, Christos E. , Hammers, Hans J. , Tsao, Che‐Kai, Pal, Sumanta K. , Hussain, Arif , Borham, Azah, George, Daniel J. , Vaishampayan, Ulka , Harrison, Michael R. , Bhavsar, Nrupen Anjan , Stadler, Walter M. , Appleman, Leonard J. , Jim, Heather

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16097-e16097

10.1200/jco.2016.34.15_suppl.e16097 Get It

Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.
Wolf, Steven , Costello, Brian A. , Vaishampayan, Ulka N. , Kyriakopoulos, Christos E. , Hammers, Hans J. , Tsao, Che‐Kai, Pal, Sumanta K. , Hussain, Arif , Borham, Azah, George, Daniel J. , Vaishampayan, Ulka , Harrison, Michael R. , Bhavsar, Nrupen Anjan , Stadler, Walter M. , Appleman, Leonard J. , Jim, Heather

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16084-e16084

10.1200/jco.2016.34.15_suppl.e16084 Get It